Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Vedang Murthy MD

Vedang Murthy MD

Professor and Radiation Oncologist, Department of Radiation Oncology, Tata Memorial Hospital, Mumbai, India

Vedang Murthy, MD, DNB, DipEPP, is a Professor and Radiation Oncologist at Tata Memorial Hospital, Mumbai. Dr. Murthy did his training in the field of Radiation Oncology from Tata Memorial Hospital and The Royal Marsden NHS Foundation Hospital, London. He also undertook a Diploma in Epidemiology and Biostatistics from the London School of Health and Tropical Medicine. He has over 200 publications in peer reviewed international journals. 

Dr. Murthy is the Convenor of Uro Oncology at Tata Hospital and currently running several investigator initiated clinical trials including randomised controlled trials in prostate and bladder cancer and is a part of international co-operative groups in GU Oncology. The main areas of interest within GU oncology are high risk prostate cancer, SBRT for prostate and kidney cancer, oligometastatic prostate cancer, bladder preservation and adjuvant radiotherapy in bladder cancer.

Disclosures

Dr. Murthy is the PI of the PRIME trial.

Recent Contributions to PracticeUpdate:

  1. Stereotactic Body Radiotherapy for Localized Prostate Cancer